Kenta Yamamoto

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Placebo Controlled

Electronic Health Record

Metastatic Colorectal Cancer

Top Venues

Journal of gastroenterology and hepatology

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Kenta Yamamoto, Takashi Honda, Yosuke Inukai, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Hiroki Kawashima
Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease. Microorganisms 12 (3) (2024)
Kenta Yamamoto, Takashi Honda, Yosuke Inukai, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Hiroki Kawashima
Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease. Microorganisms 12 (3) (2024)
Yosuke Inukai, Kenta Yamamoto, Takashi Honda, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Masatoshi Ishigami, Hiroki Kawashima
Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers 16 (9) (2024)
Yosuke Inukai, Kenta Yamamoto, Takashi Honda, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Masatoshi Ishigami, Hiroki Kawashima
Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers 16 (9) (2024)
Kenta Yamamoto, Takashi Honda, Yosuke Inukai, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Hiroki Kawashima
Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease. Microorganisms 12 (3) (2024)
Shuji Ikegami, Masanao Nakamura, Takashi Honda, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Eri Ishikawa, Kenta Yamamoto, Satoshi Furune, Takuya Ishikawa, Kazuhiro Furukawa, Eizaburo Ohno, Masatoshi Ishigami, Fumie Kinoshita, Yoshihiro Kadota, Takumi Tochio, Yoshiharu Shimomura, Yoshiki Hirooka, Hiroki Kawashima
Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study. Alimentary pharmacology & therapeutics (2023)
Kenta Yamamoto, Takashi Honda, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Masanao Nakamura, Ryoji Miyahara, Hiroki Kawashima, Masatoshi Ishigami, Mitsuhiro Fujishiro
The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C. Journal of gastroenterology and hepatology 36 (3) (2020)